Bids Are Invited For Annual Acquisition 2025/2026 Of Injectable General Medicines - Group 03

Tranexamic Acid, Adenosine, Human Albumin, Alphaepoetin, Pulmonary Surfactant, Alpostadil, Alteplase, Aminophylline, Amiodarone, Atropine Sulfate, Betamethasone, Bromeprida, Caffeine, Ferric Carboxyllate, Ketoprofen, Cloridate Hydrochloride, Sodium Dantrolene, Delaonoside, Delaonos Dexamethasone, Diclofenac, Diphenylorderum Hydrochloride, Sodium Dipyrone, Dobutamine Hydrochloride, Dopamine, Ephedrine, Enoxaparin, Epinephrine, Scopolamine Buttylbrometh, Smolol Hydrochloride, Ethylephin Hydrochloride, Filgrastim, Phytomenadi, Furosemide, Sodium Heparin, Heparin, Heparin Hiraluronidase, Hydralazine, Hydrocortisone, Human Immunoglobulin, Insulin, Metilegometrine Maleate, Methylprednisolone, Metoclopramide Hydrochloride, Metoprolol, Milhine, Oleato Ethanolamine, Nitroglycerin, Nitroprusside Of Sodium, Norepinephrine, Ocitocin, Oocinocin, Oocinocin Octreotide, Trace Elements, Omeprazole, Wavenstron Of Hydrochloride, Pantoprazole, Polydocanol, B -Complex Vitamins, Multivitamines, Promise Hydrochloride, Protamine Hydrochloride, Iron Iii, Salbutamol, Tenoxicam, Terlipressin, Trometamol, Vasopressin, Thiamine, Thiamine, Thiamine Cyanocobalamin, Ascorbic Acid